These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8371891)

  • 1. Improved detection of hepatic lesions using MoAb B72.3 and a modified 111In labelling technique in patients with recurrent colon cancer.
    Vijayakumar V; Blend MJ; Johnson DK; Seevers RH; Schnobrich KE; Bekerman C
    Nucl Med Commun; 1993 Aug; 14(8):658-66. PubMed ID: 8371891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer.
    Doerr RJ; Herrera L; Abdel-Nabi H
    Cancer; 1993 Jun; 71(12 Suppl):4241-7. PubMed ID: 8508386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer.
    Yokoyama K; Carrasquillo JA; Chang AE; Colcher D; Roselli M; Sugarbaker P; Sindelar W; Reynolds JC; Perentesis P; Gansow OA
    J Nucl Med; 1989 Mar; 30(3):320-7. PubMed ID: 2738661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of recurrent colon cancer with In-111 labeled MoAb B72.3 in a patient with normal CEA and TAG-72 levels.
    Vijayakumar V; Blend MJ; Johnson D; Schnobrich K; Golick J
    Clin Nucl Med; 1992 Mar; 17(3):180-4. PubMed ID: 1611787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site-specific immunoconjugates.
    Maguire RT; Pascucci VL; Maroli AN; Gulfo JV
    Cancer; 1993 Dec; 72(11 Suppl):3453-62. PubMed ID: 8242578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugate.
    Chetanneau A; Barbet J; Peltier P; Le Doussal JM; Gruaz-Guyon A; Bernard AM; Resche I; Rouvier E; Bourguet P; Delaage M
    Nucl Med Commun; 1994 Dec; 15(12):972-80. PubMed ID: 7715897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative gamma detection probe with presurgical antibody imaging in colon cancer.
    Kuhn JA; Corbisiero RM; Buras RR; Carroll RG; Wagman LD; Wilson LA; Yamauchi D; Smith MM; Kondo R; Beatty JD
    Arch Surg; 1991 Nov; 126(11):1398-403. PubMed ID: 1747053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.
    Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP
    Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of radiolabelled monoclonal antibodies in patients with primary and metastatic large bowel cancer.
    Sergile SL; Haller DG; Daly JM
    Surg Oncol; 1992 Dec; 1(6):391-8. PubMed ID: 1341276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma.
    Abdel-Nabi HH; Doerr RJ
    Targeted Diagn Ther; 1992; 6():73-88. PubMed ID: 1576351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts.
    Esteban JM; Schlom J; Gansow OA; Atcher RW; Brechbiel MW; Simpson DE; Colcher D
    J Nucl Med; 1987 May; 28(5):861-70. PubMed ID: 3106595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoscintigraphy of recurrent colorectal carcinoma using 111In-labelled murine monoclonal antibody B72.3: a comparison with contrast-enhanced computed tomography.
    Kmiot WA; Stonelake P; Sagar G; Donovan IA; Neoptolemos JP; Notghi A; Harding LK
    Nucl Med Commun; 1993 Sep; 14(9):788-91. PubMed ID: 8233244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 111In-CYT-103 scanning in recurrent colorectal cancer--does it affect standard management?
    Dominguez JM; Wolff BG; Nelson H; Forstrom LA; Mullan BP
    Dis Colon Rectum; 1996 May; 39(5):514-9. PubMed ID: 8620800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
    Barbet J; Peltier P; Bardet S; Vuillez JP; Bachelot I; Denet S; Olivier P; Leccia F; Corcuff B; Huglo D; Proye C; Rouvier E; Meyer P; Chatal JF
    J Nucl Med; 1998 Jul; 39(7):1172-8. PubMed ID: 9669389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer.
    Petersen BM; Bass BL; Bates HR; Chandeysson PL; Harmon JW
    Am J Surg; 1993 Jan; 165(1):137-42; discussion 142-3. PubMed ID: 8418688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved tumor localization with increasing dose of indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE-025 in metastatic colorectal cancer.
    Patt YZ; Lamki LM; Haynie TP; Unger MW; Rosenblum MG; Shirkhoda A; Murray JL
    J Clin Oncol; 1988 Aug; 6(8):1220-30. PubMed ID: 3045263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved sarcoma imaging and reduced hepatic activity with indium-111-SCN-Bz-DTPA linked to MoAb 19-24.
    Blend MJ; Greager JA; Atcher RW; Brown JM; Brechbiel MW; Gansow OA; Das Gupta TK
    J Nucl Med; 1988 Nov; 29(11):1810-6. PubMed ID: 3183749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunodetection of colorectal carcinoma.
    Artiko V; Obradovic V; Davidovic B; Petrovic N; Petrovic M; Krivokapic Z; Kecmanovic D; Pesko P; Djukic V; Milosavljevic T; Adanja G; Vlajkovic M
    Hepatogastroenterology; 2003; 50(52):1029-31. PubMed ID: 12845972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
    Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC
    Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indium-111 monoclonal antibody B72.3 scintigraphy in colorectal cancer. Correlation with computed tomography, surgery, histopathology, immunohistology, and human immune response.
    Winzelberg GG; Grossman SJ; Rizk S; Joyce JM; Hill JB; Atkinson DP; Sudina K; Anderson K; McElwain D; Jones AM
    Cancer; 1992 Apr; 69(7):1656-63. PubMed ID: 1551051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.